Over-expression of angiogenic/invasive factors, including VEGF and MMP9, was found in patients with chronic lymphocytic leukemia (CLL), and microvessel count in tumor microenvironment was positively correlated to the clinical stage of these patients [29], [30], [31]. This evidence concerns the gene MMP9 and B-cell chronic lymphocytic leukemia.